SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-006268
Filing Date
2019-04-12
Accepted
2019-04-12 16:14:57
Documents
4
Period of Report
2019-04-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k041019b_immucellcorp.htm 8-K 17618
2 LETTER FROM RSM US LLP TO THE SECURITIES AND EXCHANGE COMMISSION. f8k041019bex16-1_immucell.htm EX-16.1 2494
3 GRAPHIC image_001.jpg GRAPHIC 7096
4 GRAPHIC image_002.jpg GRAPHIC 2204
  Complete submission text file 0001213900-19-006268.txt   34282
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 19746443
SIC: 2835 In Vitro & In Vivo Diagnostic Substances